Chemeq says it will meet production requirements

By Melissa Trudinger
Tuesday, 08 March, 2005

Chemeq (ASX:CMQ) has clarified its current and future production capabilities after questions were raised in a research report about the ability of the company to produce the levels of product required by new investment partner Mizuho.

As one of the conditions of the company's AUD$60 million rescue by Mizuho, Chemeq is required to obtain confirmed sales orders for a minimum of 40,000 litres of its polymeric antimicrobial in the 2005-2006 financial year by the end of September this year.

But a recent issue of biotech investor newsletter Bioshares questioned whether the company's production levels were adequate to meet this.

Now the company has confirmed that its current production levels are 60,000-100,000 litres of product, which equates to approximately 15-25 per cent of plant capacity. Ultimately, the plant is expected to reach a production output of 400,000 litres of finished product.

Related News

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd